An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 have?

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 has 1,954 citations in the OpenAlex counts ScholarIQ stores.

When was An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 published?

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 has 2021 year in the ScholarIQ index.

What is the open-access status of An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19?

An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 has hybrid oa status in the ScholarIQ index.

What is the DOI of An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19?

The DOI for An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 is on the source record.

What is the PMID of An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19?

The PMID for An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 is on the source record.

What is the OpenAlex record for An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19?

The OpenAlex for An oral SARS-CoV-2 M ^pro inhibitor clinical candidate for the treatment of COVID-19 is on the source record.